Remove Bioinformatics Remove Genetic Engineering Remove Marketing
article thumbnail

Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments

The Pharma Data

Teneobio’s discovery platform, TeneoSeek, comprises genetically engineered animals (UniRat® and OmniFlic®), next-generation sequencing, bioinformatics and high-throughput vector assembly technologies. About Teneobio Teneobio, Inc.

article thumbnail

United Therapeutics Corporation Reports Third Quarter 2020 Financial Results

The Pharma Data

The decrease in Adcirca revenues was driven by continued erosion of market share due to generic competition. Sales and marketing. Cash, cash equivalents, and marketable investments. Cost of product sales. Dollar Change. .